We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+18.11%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$337M
AUM Growth
+$72.5M
Cap. Flow
+$27.3M
Cap. Flow %
8.09%
Top 10 Hldgs %
59.41%
Holding
1,982
New
245
Increased
570
Reduced
606
Closed
239

Sector Composition

Rank Sector Weight
1 Financials 13.05%
2 Technology 10.18%
3 Healthcare 3.61%
4 Communication Services 3.22%
5 Consumer Discretionary 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYPL icon
101
PayPal
PYPL
$50.5B
$263K 0.08%
1,508
-21
-1% -$2.9K
HQH
102
abrdn Healthcare Investors
HQH
$1.32B
$253K 0.08%
11,850
-1,950
-14% -$39.7K
ZTS icon
103
Zoetis
ZTS
$30B
$239K 0.07%
1,745
-12
-0.7% -$1.57K
ABT icon
104
Abbott
ABT
$187B
$238K 0.07%
2,601
+34
+1% +$3.07K
MDLZ icon
105
Mondelez International
MDLZ
$79.9B
$235K 0.07%
4,597
-326
-7% -$16.7K
BX icon
106
Blackstone
BX
$110B
$227K 0.07%
4,000
LLY icon
107
Eli Lilly
LLY
$1.06T
$222K 0.07%
1,355
+102
+8% +$15.7K
AZN icon
108
AstraZeneca
AZN
$250B
$221K 0.07%
2,088
+247
+13% +$25.5K
CVS icon
109
CVS Health
CVS
$122B
$218K 0.06%
3,357
+1,048
+45% +$66K
IWD icon
110
iShares Russell 1000 Value ETF
IWD
$83.7B
$218K 0.06%
1,940
+714
+58% +$78.5K
TLT icon
111
iShares 20+ Year Treasury Bond ETF
TLT
$41.7B
$218K 0.06%
1,328
-1,669
-56% -$275K
PRF icon
112
Invesco FTSE RAFI US 1000 ETF
PRF
$10B
$217K 0.06%
10,000
C icon
113
Citigroup
C
$226B
$215K 0.06%
4,201
+334
+9% +$15.8K
UNP icon
114
Union Pacific
UNP
$174B
$214K 0.06%
1,266
-22
-2% -$3.53K
NVO
115
Novo Nordisk
NVO
$209B
$213K 0.06%
6,518
+300
+5% +$9.57K
NVS icon
116
Novartis
NVS
$297B
$210K 0.06%
2,410
-108
-4% -$9.32K
BXP icon
117
Boston Properties
BXP
$11.1B
$209K 0.06%
2,313
-82
-3% -$7.44K
SPGI icon
118
S&P Global
SPGI
$120B
$209K 0.06%
634
+116
+22% +$34.9K
COP icon
119
ConocoPhillips
COP
$141B
$206K 0.06%
4,902
-461
-9% -$18.6K
GLD icon
120
SPDR Gold Trust
GLD
$141B
$205K 0.06%
1,226
TMO icon
121
Thermo Fisher Scientific
TMO
$220B
$204K 0.06%
563
-11
-2% -$3.69K
SONY icon
122
Sony
SONY
$138B
$203K 0.06%
14,700
+305
+2% +$3.96K
UBS icon
123
UBS Group
UBS
$176B
$202K 0.06%
17,473
-2,168
-11% -$22.3K
ASML icon
124
ASML
ASML
$669B
$195K 0.06%
531
+34
+7% +$10.7K
EMR icon
125
Emerson Electric
EMR
$88.3B
$190K 0.06%
3,067
+58
+2% +$3.29K

Similar funds

Lindbrook Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Lindbrook Capital held 1,982 positions worth $337M, up 27% from $265M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Lindbrook Capital deployed $27.3M of net new capital in Q2 2020, opening 245 new positions and adding to 570 existing holdings. Its largest new stake was JPMorgan Ultra-Short Income ETF: 25,500 shares worth $1.29M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 9.1% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $3.07M trimmed.

  • Lindbrook Capital's largest Q2 2020 buy was JPMorgan Ultra-Short Income ETF: 25,500 shares worth $1.29M.
  • Lindbrook Capital added most to Golub Capital BDC in Q2 2020, an estimated $20.9M increase.
  • Lindbrook Capital's biggest Q2 2020 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $3.07M.
  • Lindbrook Capital fully exited Broadmark Realty Capital Inc. Common Stock in Q2 2020, selling an estimated $3.56M.
  • Lindbrook Capital's ten largest holdings make up 59% of its $337M portfolio in Q2 2020.
  • Lindbrook Capital opened 245 new positions and closed 239 in Q2 2020.
  • Lindbrook Capital's portfolio value rose 27% quarter-over-quarter to $337M.

Based on Lindbrook Capital's 13F filing for Q2 2020, filed 27 Jul 2020.